Gilead Rallies Off Epclusa Approval
June 28, 2016 at 11:42 AM EDT
Gilead Sciences, Inc. (NASDAQ: GILD) shares are trading higher by $2.63 at $80.88 in Tuesday's session. The catalyst for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.